Facebook
X
LinkedIn
ForwardSeries date:
07/01/2020 - 6:30am CDT to 12/31/2020 - 7:30am CST
OBJECTIVES: Upon completion of this activity, the participant should be able to: (1) Identify MSTS/CTOS guidelines for treatment of sarcomas, (2) Recognize common presenting signs and symptoms of sarcoma and musculoskeletal tumors, (3) Identify specific imaging patterns and characteristics for sarcoma and musculoskeletal tumors, (4) Analyze treatment modalities applicable to sarcoma and musculoskeletal tumors, (5) Identify clinical trials available for sarcoma through SARC
FACULTY DISCLOSURE: Allaaddin Mollabashy, MD does not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
PLANNERS DISCLOSURES: Allaaddin Mollabashy, MD and Scott Cheek, MD do not have a relevant financial interest or affiliation with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information please contact Rachel Waller at [email protected]
Series location:
Texas Oncology-Baylor Charles A. Sammons Cancer Center
3401 Worth Street, Ste 400
Dallas, TX
75246
United States
See map: Google Maps